Interferons: Between structure and function;Interferony: między strukturą a funkcją

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 68, Issue , 2014, Pages 428-440

  Bandurska, Katarzyna ^a   Król, Izabela ^a   Myga Nowak, Magdalena ^a  

^a JAN DLUGOSZ UNIVERSITY   (Poland)

Author keywords

Antiviral protection; II; III; Interferon receptors; Interferons type I

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; GAMMA INTERFERON; INTERFERON; PROTECTIVE AGENT; VIRUS PROTEIN; VIRUS RNA;

ANIMAL; APOPTOSIS; CHEMISTRY; CLASSIFICATION; HUMAN; IMMUNOLOGY; METABOLIC ACTIVATION; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ACTIVATION, METABOLIC; ANIMALS; ANTIVIRAL AGENTS; APOPTOSIS; HUMANS; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERFERONS; PROTECTIVE AGENTS; RNA, VIRAL; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

EID: 84920599174     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1101229     Document Type: Review

References (109)

1. Adolf G.R., Kalsner I., Ahorn H., Maurer-Fogy I., Cantell K.: Natural human interferon-α2 is O-glycosylated. Biochem J., 1991; 276: 511-518
2. Adolf G.R., Maurer-Fogy I., Kalsner I., Cantell K.: Purification and characterization of natural human interferon ω1. Two alternative cleavage sites for the signal peptidase. J Biol. Chem., 1990; 265: 9290-9295
3. Ank N., West H., Paludan S.R.: IFN-γ: novel antiviral cytokines. J. Interferon Cytokine Res., 2006; 26: 373-379
4. Benson D.A., Karsch-Mizrachi I., Lipman D.J., Ostell J., Wheeler D.L.: GenBank. Nucleic Acids Res., 2005; 33: D34-D38
5. Billiau A.: Interferons: the pathways of discovery. II. Immunomodulatory, in vivo and applied aspects. J. Clin. Virol., 2007; 39: 241-265
6. Bloom B.R., Bennett B.: Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science, 1966; 153: 80-82
7. Bream J.H., Ping A., Zhang X., Winkler C., Young H.A.: A single nucleotide polymorphism in the proximal IFN-gamma promoter alters control of gene transcription. Genes Immun., 2002; 3: 165-169
8. Capobianchi M.R., Mattana P., Mercuri F., Conciatori G., Ameglio F., Ankel H., Dianzani F.: Acidlability is not an intrinsic property of interferon-alpha induced by HIV-infected cells. J. Interferon Res., 1992; 12: 431-438
9. Cederblad B., Gobl A.E., Alm G.V.: The induction of interferon-alpha and interferon-beta mRNA in human natural interferon-producing blood leukocytes requires de novo protein synthesis. J. Interferon Res., 1991; 11: 371-377
10. Chakrabarti A., Jha B.K., Silverman R.H.: New insights into the role of RNase L in innate immunity. J. Interferon Cytokine Res., 2011; 31: 49-57
11. Chevillard C., Henri S., Stefani F., Parzy D., Dessein A.: Two new polymorphisms in the human interferon gamma (IFN-γ) promoter. Eur. J. Immunogenet., 2002; 29: 53-56
12. Choubey D., Moudgil K.D.: Interferons in autoimmune and inflammatory diseases: regulation and roles. J. Interferon Cytokine Res., 2011; 31: 857-865
13. Cutrone E.C., Langer J.A.: Identification of critical residues in bovine IFNAR-1 responsible for interferon binding. J. Biol. Chem., 2001; 276: 17140-17148
14. De Maeyer E., De Maeyer-Guignard J.: Type I interferons. Int. Rev. Immunol., 1998; 17: 53-73
15. Dempoya J., Matsumiya T., Imaizumi T., Hayakari R., Xing F., Yoshida H., Okumura K., Satoh K.: Double-stranded RNA induces biphasic STAT1 phosphorylation by both type I interferon (IFN)- dependent and type I IFN-independent pathways. J. Virol., 2012; 86: 12760-12769
16. Devos R., Cheroutre H., Taya Y., Fiers W.: Isolation and characterization of IFN-gamma mRNA derived from mitogen-induced human splenocytes. J. Interferon Res., 1982; 2: 409-420
17. Díaz M.O., Pomykala H.M., Bohlander S.K., Maltepe E., Malik K., Brownstein B., Olopade O.I.: Structure of the human type-I interferon gene cluster determined from a YAC clone contig. Genomics, 1994; 22: 540-552
18. Feldman S.B., Ferraro M., Zheng H.M., Patel N., Gould-Fogerite S., Fitzgerald-Bocarsly P.: Viral induction of low frequency interferon-α producing cells. Virology, 1994; 204: 1-7
19. Flaishon L., Hershkoviz R., Lantner F., Lider O., Alon R., Levo Y., Flavell R.A., Shachar I.: Autocrine secretion of interferon γ negatively regulates homing of immature B cells. J. Exp. Med., 2000; 192: 1381-1388
20. Flores I., Mariano T.M., Pestka S.: Human interferon omega (ω) binds to the α/β receptor. J. Biol. Chem., 1991; 266: 19875-19877
21. Fountoulakis M., Zulauf M., Lustig A., Garotta G.: Stoichiometry of interaction between interferon γ and its receptor. Eur. J. Biochem., 1992; 208: 781-787
22. Gentles A.J., Karlin S.: Why are human G-protein-coupled receptors predominantly intronless? Trends Genet., 1999; 15: 47-49
23. George C.X., Gan Z., Liu Y., Samuel C.E.: Adenosine deaminases acting on RNA, RNA editing, and interferon action. J. Interferon Cytokine Res., 2011; 31: 99-117
24. George P.M., Badiger R., Alazawi W., Foster G.R., Mitchell J.A.: Pharmacology and therapeutic potential of interferons. Pharmacol. Ther., 2012; 135: 44-53
25. Gibbs V.C., Takahashi M., Aguet M., Chuntharapai A.: A negative regulatory region in the intracellular domain of the human interferon-α receptor. J. Biol. Chem., 1996; 271: 28710-28716
26. Gołąb J., Jakóbisiak M., Lasek W., Stokłosa T.: Immunologia. Wydawnictwo Naukowe PWN, Warszawa 2012
27. González-Navajas J.M., Lee J., David M., Raz E.: Immunomodulatory functions of type I interferons. Nat. Rev. Immunol., 2012; 12: 125-135
28. Gray P.W., Goeddel D.V.: Structure of the human immune interferon gene. Nature, 1982; 298: 859-863
29. Hardy M.P., Owczarek C.M., Jermiin L.S., Ejdebäck M., Hertzog P.J.: Characterization of the type I interferon locus and identification of novel genes. Genomics, 2004; 84: 331-345
30. Hauptmann R., Swetly P.: A novel class of human type I interferons. Nucleic Acids Res., 1985; 13: 4739-4749
31. Hayden C., Pereira E., Rye P., Palmer L., Gibson N., Palenque M., Hagel I., Lynch N., Goldblatt J., Lesouëf P.: Mutation screening of interferon-gamma (IFNgamma) as a candidate gene for asthma. Clin. Exp. Allergy, 1997; 27: 1412-1416
32. Henri S., Stefani F., Parzy D., Eboumbou C., Dessein A., Chevillard C.: Description of three new polymorphisms in the intronic and 3'UTR regions of the human interferon gamma gene. Genes Immun., 2002; 3: 1-4
33. Hertzog P.J., O'Neill L.A., Hamilton J.A.: The interferon in TLR signaling: more than just antiviral. Trends Immunol., 2003; 24: 534-539
34. Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I. i wsp.: DNA sequence and analysis of human chromosome 9. Nature, 2004; 429: 369-374
35. Jung V., Rashidbaigi A., Jones C., Tischfield J.A., Shows T.B., Pestka S.: Human chromosomes 6 and 21 are required for sensitivity to human interferon γ. Proc. Natl. Acad. Sci. USA, 1987; 84: 4151-4155
36. Karpusas M., Nolte M., Benton C.B., Meier W., Lipscomb W.N., Goelz S.: The crystal structure of human interferon β at 2.2-A resolution. Proc. Natl. Acad. Sci. USA, 1997; 94: 11813-11818
37. Kawamoto S., Oritani K., Asakura E., Ishikawa J., Koyama M., Miyano K., Iwamoto M., Yasuda S., Nakakubo H., Hirayama F., Ishida N., Ujiie H., Masaie H., Tomiyama Y.: A new interferon, limitin, displays equivalent immunomodulatory and antitumor activities without myelosuppressive properties as compared with interferon-α. Exp. Hematol., 2004; 32: 797-805
38. Khani-Hanjani A., Lacaille D., Hoar D., Chalmers A., Horsman D., Anderson M., Balshaw R., Keown P.A.: Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis. Lancet, 2000; 356: 820-825
39. Klaus W., Gsell B., Labhardt A.M., Wipf B., Senn H.: The three-dimensional high resolution structure of human interferon α-2a determined by heteronuclear NMR spectroscopy in solution. J. Mol. Biol., 1997; 274: 661-675
40. Kontsek P.: Human type I interferons: structure and function. Acta Virol., 1994; 38: 345-360
41. Kotenko S.V.: The family of IL-10-related cytokines and their receptors: related, but to what extent? Cytokine Growth Factor Rev., 2002; 13: 223-240
42. Kotenko S.V., Donnelly R.P.: Type III interferons: The Interferon-λ family. W: The interferons. Characterization and application. Meager A.Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim 2006; 141-163
43. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., Langer J.A, Sheikh F., Dickensheets H., Donelly R.P.: IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol., 2003; 4: 69-77
44. Krause C.D., Mei E., Xie J., Jia Y., Bopp M.A., Hochstrasser R.M., Pestka S.: Seeing the light: preassembly and ligand-induced changes of the interferon γ receptor complex in cells. Mol. Cell. Proteomics, 2002; 1: 805-815
45. Krause C.D., Pestka S.: Evolution of the class 2 cytokines and receptors, and discovery of new friends and relatives. Pharmacol. Ther., 2005; 106: 299-346
46. LaFleur D.W., Nardelli B., Tsareva T., Mather D., Feng P., Semenuk M., Taylor K., Buergin M., Chinchilla D., Roshke V., Chen G., Ruben S.M., Pitha P.M., Coleman T.A., Moore P.A.: Interferon-κ, a novel type I interferon expressed in human keratinocytes. J. Biol. Chem., 2001; 276: 39765-39771
47. Lamken P., Gavutis M., Peters I., Van der Heyden J., Uzé G., Piehler J.: Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1. J. Mol. Biol., 2005; 350: 476-488
48. Lee N., Ni D., Brissette R., Chou M., Hussain M., Gill D.S., Liao M.J., Testa D.: Interferon-alpha 2 variants in the human genome. J. Interferon Cytokine Res., 1995; 15: 341-349
49. Lefèvre F., Boulay V.: A novel and atypical type one interferon gene expressed by trophoblast during early pregnancy. J. Biol. Chem., 1993; 268: 19760-19768
50. Lefèvre F., Guillomot M., D'Andréa S., Battegay S., La Bonnardière C.: Interferon-delta: the first member of a novel type I interferon family. Biochimie, 1998; 80: 779-788
51. Li G., Xiang Y., Sabapathy K., Silverman R.H.: An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase. J. Biol. Chem., 2004; 279: 1123-1131
52. Li M., Liu X., Zhou Y., Su S.B.: Interferon-λs: the modulators of antivirus, antitumor, and immune responses. J. Leukoc. Biol., 2009; 86: 23-32
53. Lindenmann J., Burke D.C., Isaacs A.: Studies on the production, mode of action and properties of interferon. Br. J. Exp. Pathol., 1957; 38: 551-562
54. Malmgaard L.: Induction and regulation of IFNs during viral infections. J. Interferon Cytokine Res., 2004; 24: 439-454
55. Matsuda S., Kawano G., Itoh S., Mitsui Y., Iitaka Y.: Crystallization and preliminary X-ray studies of recombinant murine interferon-β. J. Biol. Chem., 1986; 261: 16207-16209
56. Matsuda S., Senda T., Itoh S., Kawano G., Mizuno H., Mitsui Y.: New crystal form of recombinant murine interferon-β. J. Biol. Chem., 1989; 264: 13381-13382
57. Meager A.: The Interferons. Characterization and Application. Wiley-VHC Verlag GmbH & Co. KGaA 2006
58. Meyer M.D., Hansen P.J., Thatcher W.W., Drost M., Badinga L., Roberts R.M., Li J., Ott T.L., Bazer F.W.: Extension of corpus luteum lifespan and reduction of uterine secretion of prostaglandin F2α of cows in response to recombinant interferon-τ. J. Dairy Sci., 1995; 78: 1921-1931
59. Miller D.L., Kung H.F., Pestka S.: Crystallization of recombinant human leukocyte interferon A. Science, 1982; 215: 689-690
60. Nagarajan U.: Induction and function of IFNβ during viral and bacterial infection. Crit. Rev. Immunol., 2011; 31: 459-474
61. Nardelli B., Zaritskaya L., Semenuk M., Cho Y.H., LaFleur D.W., Shah D., Ullrich S., Girolomoni G., Albanesi C., Moore P.A.: Regulatory effect of IFN-κ, a novel type I IFN, on cytokine production by cells of the innate immune system. J. Immunol., 2002; 169: 4822-4830
62. Nathan C.F., Murray H.W., Wiebe M.E., Rubin B.Y.: Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med., 1983; 158: 670-689
63. Nyman T.A., Kalkkinen N., Tölö H., Helin J.: Structural characterisation of N-linked and O-linked oligosaccharides derived from interferon-α2b and interferon-α14c produced by Sendai-virus-induced human peripheral blood leukocytes. Eur. J. Biochem., 1998; 253: 485-493
64. Ohlsson M., Feder J., Cavalli-Sforza L.L., von Gabain A.: Close linkage of α and β interferons and infrequent duplication of β interferon in humans. Proc.Natl. Acad. Sci. USA, 1985; 82: 4473-4476
65. Oritani K., Hirota S., Nakagawa T., Takahashi I., Kawamoto S., Yamada M., Ishida N., Kadoya T., Tomiyama Y., Kincade P.W., Matsuzawa Y.: T lymphocytes constitutively produce an interferonlike cytokine limitin characterized as a heat- and acid-stable and heparin-binding glycoprotein. Blood, 2003; 101: 178-185
66. Oritani K., Kincade P.W., Tomiyama Y.: Limitin: an interferon-like cytokine without myeloerythroid suppressive properties. J. Mol. Med., 2001; 79: 168-174
67. Oritani K., Medina K.L., Tomiyama Y., Ishikawa J., Okajima Y., Ogawa M., Yokota T., Aoyama K., Takahashi I., Kincade P.W., Matsuzawa Y.: Limitin: an interferon-like cytokine that preferentially influences B-lymphocyte precursors. Nat. Med., 2000; 6: 659-666
68. Oritani K., Tomiyama Y.: Interferon-zeta/limitin: novel type I interferon that displays a narrow range of biological activity. Int. J. Hematol., 2004; 80: 325-331
69. Piasecki E.: Human acid-labile interferon α. Arch. Immunol. Ther. Exp., 1999; 47: 89-98
70. Piasecki E., Knysz B., Gasiorowski J., Gładysz A.: Decrease of enhanced interferon alpha levels in sera of HIV-infected and AIDS pa tients receiving combined antiretroviral therapy. Arch. Immunol. Ther. Exp., 1999; 47: 37-44
71. Pestka S.: The interferons: 50 years after their discovery, there is much more to learn. J. Biol. Chem., 2007; 282: 20047-20051
72. Pestka S., Kotenko S.V., Muthukumaran G., Izotova L.S., Cook J.R., Garotta G.: The interferon gamma (IFN-gamma) receptor: a paradigm for the multichain cytokine receptor. Cytokine Growth Factor Rev., 1997; 8: 189-206
73. Pestka S., Krause C.D.: Interferon and related receptors. W: The interferons. Characterization and application. Meager A. Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim 2006; 113-140
74. Pestka S., Krause C.D., Walter M.R.: Interferons, interferon-like cytokines, and their receptors. Immunol. Rev., 2004; 202: 8-32
75. Pestka S., Langer J.A., Zoon K.C., Samuel C.E.: Interferons and their actions. Annu. Rev. Biochem., 1987; 56: 727-777
76. Piehler J., Roisman L.C., Schreiber G.: New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface. J. Biol. Chem., 2000; 275: 40425-40433
77. Pitha P.M. (red.): Interferon: the 50th anniversary. Curr. Top. Microbiol. Immunol., 2007; 316
78. Platanias L.C.: Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol., 2005; 5: 375-386
79. Pletneva L.M., Haller O., Porter D.D., Prince G.A., Blanco J.C.: Interferon-inducible Mx gene expression in cotton rats: cloning, characterization, and expression during influenza viral infection. J. Interferon Cytokine Res., 2006; 26: 914-921
80. Pravica V., Perrey C., Stevens A., Lee J.H., Hutchinson I.V.: A single nucleotide polymorphism in the first intron of the human IFN-γ gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-γ production. Hum. Immunol., 2000; 61: 863-866
81. Radhakrishnan R., Walter L.J., Hruza A., Reichert P., Trotta P.P., Nagabhushan T.L., Walter M.R.: Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography. Structure, 1996; 4: 1453-1463
82. Radhakrishnan R., Walter L.J., Subramaniam P.S., Johnson H.M., Walter M.R.: Crystal structure of ovine interferon-tau at 2.1 A resolution. J. Mol. Biol., 1999; 286: 151-162
83. Rashidbaigi A., Langer J.A., Jung V., Jones C., Morse H.G., Tischfield J.A., Trill J.J., Kung H.F., Pestka S.: The gene for the human immune interferon receptor is located on chromosome 6. Proc. Natl. Acad. Sci. USA, 1986; 83: 384-388
84. Roberts R.M., Ezashi T., Rosenfeld C.S., Ealy A.D., Kubisch H.M.: Evolution of the interferon tau genes and their promoters, and maternal-trophoblast interactions in control of their expression. Reprod. Suppl., 2003; 61: 239-251
85. Runkel L., Meier W., Pepinsky R.B., Karpusas M., Whitty A., Kimball K., Brickelmaier M., Muldowney C., Jones W., Goelz S.E.: Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta). Pharm. Res., 1998; 15: 641-649
86. Sadler A.J., Williams B.R.: Interferon-inducible antiviral effectors. Nat. Rev. Immunol., 2008; 8: 559-568
87. Sakharkar M.K., Chow V.T., Chaturvedi I., Mathura V.S., Shapshak P., Kangueane P.: A report on single exon genes (SEG) in eukaryotes. Front. Biosci., 2004; 9: 3262-3267
88. Sakharkar M.K., Chow V.T., Kangueane P.: Distributions of exons and introns in the human genome. In Silico Biol., 2004; 4: 387-393
89. Sakharkar M.K., Kangueane P.: Genome SEGE: a database for 'intronless' genes in eukaryotic genomes. BMC Bioinformatics, 2004; 5: 67
90. Sakharkar M.K., Kangueane P., Petrov D.A., Kolaskar A.S., Subbiah S.: SEGE: A database on 'intron less/single exonic' genes from eukaryotes. Bioinformatics, 2002; 18: 1266-1267
91. Samuel C.E.: Antiviral actions of interferons. Clin. Microbiol. Rev., 2001; 14: 778-809
92. Schroder K., Hertzog P.J., Ravasi T., Hume D.A.: Interferon-γ: an overview of signals, mechanisms and functions. J. Leukoc. Biol., 2004; 75: 163-189
93. Senda T., Saitoh S., Mitsui Y.: Refined crystal structure of recombinant murine interferon-β at 2.15 A resolution. J. Mol. Biol., 1995; 253: 187-207
94. Senda T., Shimazu T., Matsuda S., Kawano G., Shimizu H., Nakamura K.T., Mitsui Y.: Three-dimensional crystal structure of recombinant murine interferon-β. EMBO J., 1992; 11: 3193-3201
95. Sheppard P., Kindsvogel W., Xu W., Henderson K., Schlutsmeyer S., Whitmore T.E., Kuestner R., Garrigues U., Birks C., Roraback J., Ostrander C., Dong D., Shin J., Presnell S., Fox B. i wsp.: IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol., 2003; 4: 63-68
96. Siddiqui M.A., Malathi K.: RNase L induces autophagy via c-Jun N-terminal kinase and double-stranded RNA-dependent protein kinase signaling pathways. J. Biol. Chem., 2012; 287: 43651-43664
97. Stalker J., Gibbins B., Meidl P., Smith J., Spooner W., Hotz H.R., Cox A.V.: The Ensembl Web site: mechanics of a genome browser. Genome Res., 2004; 14: 951-955
98. Taya Y., Devos R., Tavernier J., Cheroutre H., Engler G., Fiers W.: Cloning and structure of the human immune interferon-γ chromosomal gene. EMBO J., 1982; 1: 953-958
99. Taylor K.E., Mossman K.L.: Recent advances in understanding viral evasion of type I interferon. Immunology, 2013; 138: 190-197
100. Trent J.M., Olson S., Lawn R.M.: Chromosomal localization of human leukocyte, fibroblast, and immune interferon genes by means of in situ hybridization. Proc. Natl. Acad. Sci. USA, 1982; 79: 7809-7813
101. van Pesch V., Lanaya H., Renauld J.C., Michiels T.: Characterization of the murine alpha interferon gene family. J. Virol., 2004; 78: 8219-8228
102. Vilcek J.: Novel interferons. Nat. Immunol., 2003; 4: 8-9
103. Walter M.R., Windsor W.T., Nagabhushan T.L., Lundell D.J., Lunn C.A., Zauodny P.J., Narula S.K.: Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor. Nature, 1995; 376: 230-235
104. Weissmann C., Weber H.: The interferon genes. Prog. Nucleic Acid Res. Mol. Biol., 1986; 33: 251-300
105. Wetzel R.: Assignment of the disulphide bonds of leukocyte interferon. Nature, 1981; 289: 606-607
106. Wetzel R., Perry L.J., Estell D.A, Lin N., Levine H.L., Slinker B., Fields F., Ross M.J., Shively J.: Properties of a human alpha-interferon purified from E. coli extracts. J. Interferon Res., 1981; 1: 381-390
107. Wheelock E.F.: Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science, 1965; 149: 310-311
108. Xu J., Gu S., Wang S., Dai J., Ji C., Jin Y., Qian J., Wang L., Ye X., Xie Y., Mao Y.: Characterization of a novel splicing variant of KLHL5, a member of the kelch protein family. Mol. Biol. Rep., 2003; 30: 239-242
109. Yoshida K.: Identification and characterization of a novel kelch-like gene KLHL15 in silico. Oncol. Rep., 2005; 13: 1133-1137